Gsk (GSK) FCF Margin (2009 - 2026)
Gsk (GSK) posted quarterly FCF Margin of 3.9% for Q2 2026, up 69.0% year-over-year from 2.31% in Q2 2025, and down 81.06% quarter-over-quarter from 20.59% in Q1 2026.
Gsk (GSK) FCF Margin (2009 - 2026) Analysis & Trends
Gsk's FCF Margin history runs 18 years deep, the most recent figure standing at 3.9% for Q2 2026.
- In Q2 2026, FCF Margin rose 69.0% year-over-year to 3.9%; the TTM figure through Jun 2026 stood at 18.13% (up 216.0% YoY), while the FY2025 annual figure was 23.25%, up 265.0% from the prior year.
- FCF Margin for Q2 2026 stood at 3.9%, down from 20.59% in the prior quarter.
- The five-year high for FCF Margin was 33.37% in Q1 2022, with the low at 3.21% in Q2 2025.
- The 5-year median for FCF Margin is 20.55% (2022), against an average of 18.23%.
- Peak annual rise in FCF Margin reached 1118 bps in 2024, while the deepest fall reached 2701 bps in 2024.
- Gsk's FCF Margin stood at 32.19% in 2022, then dropped by 29 bps to 22.8% in 2023, then climbed by 20 bps to 27.38% in 2024, then increased by 20 bps to 32.78% in 2025, then tumbled by 88 bps to 3.9% in 2026.
- Business Quant data shows GSK's FCF Margin at 3.9% in Q2 2026, 20.59% in Q1 2026, and 32.78% in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.15 Bn | 631.39 Bn | 17.26 Bn | 28.82% |
| 2 | AbbVie | 470.22 Bn | 463.65 Bn | 12.70 Bn | 18.33% |
| 3 | Merck | 375.23 Bn | 368.09 Bn | 12.21 Bn | 26.96% |
| 4 | Novartis Ag | 302.74 Bn | 295.05 Bn | 11.24 Bn | 38.60% |
| 5 | Astrazeneca | 257.45 Bn | 252.55 Bn | 12.86 Bn | -12.07% |
| 6 | Amgen | 236.97 Bn | 222.98 Bn | 7.24 Bn | 34.70% |
| 7 | Gilead Sciences | 182.72 Bn | 179.54 Bn | 6.22 Bn | 44.00% |
| 8 | Pfizer | 159.94 Bn | 148.24 Bn | 10.94 Bn | 2.01% |
| 9 | Gsk | 106.14 Bn | 101.97 Bn | 8.24 Bn | 3.90% |
| 10 | Sanofi | 55.19 Bn | 47.81 Bn | 10.79 Bn | 18.92% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.90% |
| Mar 31, 2026 | 20.59% |
| Dec 31, 2025 | 32.78% |
| Sep 30, 2025 | 3.64% |
| Jun 30, 2025 | 3.21% |
| Mar 31, 2025 | 20.08% |
| Dec 31, 2024 | 27.38% |
| Sep 30, 2024 | 3.81% |
| Jun 30, 2024 | 3.83% |
| Mar 31, 2024 | 18.66% |
| Dec 31, 2023 | 22.80% |
| Sep 30, 2023 | 30.82% |
| Jun 30, 2023 | 22.33% |
| Mar 31, 2023 | 7.48% |
| Dec 31, 2022 | 32.19% |
| Sep 30, 2022 | 20.51% |
| Jun 30, 2022 | 20.68% |
| Mar 31, 2022 | 33.37% |
| Dec 31, 2021 | 29.26% |
| Sep 30, 2021 | 37.54% |